The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (rw) study to identify disparities in outcomes for patients (pts) with early-stage resected NSCLC who received biomarker-targeted adjuvant treatment (BTRx).
 
Raymond Osarogiagbon
Employment - Baptist Memorial Healthcare Corporation/Baptist Cancer Center
Stock and Other Ownership Interests - BridgeBio Pharma; Gilead Sciences; Immunocore; Lilly; Pfizer
Honoraria - AstraZeneca; GE Healthcare; MEDIAN Technologies
Consulting or Advisory Role - American Cancer Society; AstraZeneca; Triptych Health Partners
Patents, Royalties, Other Intellectual Property - 2 US and 1 China patents for lymph node specimen collection kit and method of pathologic evaluation.
Travel, Accommodations, Expenses - American Cancer Society; GE Healthcare; MEDIAN Technologies
Other Relationship - Oncobox
 
Robert Hsu
Honoraria - DAVA Oncology; The Dedham Group
Consulting or Advisory Role - EMD Serono; Oncohost; Takeda; Targeted Oncology
Research Funding - Bristol Myers Squibb Foundation (Inst)
 
Melinda Hsu
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Mirati Therapeutics; Regeneron
 
Sandip Patel
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Certis Oncology Solutions; Compugen; Illumina; Iovance Biotherapeutics (Inst); Lilly; Lilly; Merck; Nektar; Novartis; Pfizer; Roche/Genentech; Tempus
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics; Takeda (Inst); Takeda (Inst)
 
Matthew Smeltzer
Other Relationship - Association of Community Cancer Centers (ACCC)
 
Greg Ursino
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Martina Lupicka
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Yanique Rattigan-Brown
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ilker Arslan
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Emre Baser
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Michael Stokes
Employment - Evidera PPD
 
Rajrupa Gosh
Employment - Evidera PPD
 
Charlotte Pettersson
Employment - Evidera PPD
 
Yi Liang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Martin Sandelin
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Rachel Salomonsen
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca